Todd Ridky is a Dermatology physician affiliated with University of Pennsylvania. OpenAlex indexes 215 publications with 4,396 citations (h-index 29). By OpenAlex citation count, this profile ranks in the top 10% of Dermatology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingMedicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
48.1%Azole Antifungal26.9%Ketoconazole100%Part D<11 patientsTetracycline-class Drug21.2%Doxycycline Hyclate100%Part D<11 patientsDermatology
28.8%Corticosteroid28.8%Triamcinolone Acetonide100%Part D<11 patientsSensory organs
23.1%Corticosteroid23.1%Clobetasol Propionate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
6 NIH research awards on record, funded 2010–2026 per NIH RePORTER. The latest:
- Using Nonclassical Estrogen Signaling to Prevent Melanoma
University of Pennsylvania
FY2023$419,353R01CA227188 - Using Nonclassical Estrogen Signaling to Prevent Melanoma
University of Pennsylvania
FY2022$424,200R01CA227188
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- LNS8801: An Enantiomerically Pure Agonist of the G Protein–Coupled Estrogen Receptor Suitable for Clinical Development
Cancer Research Communications
2025 - An In Vivo Study of LNS8801 , a GPER Agonist, in a Spontaneous Melanoma‐Prone Mouse Model, TGS
Pigment Cell & Melanoma Research
2024 - Targeting anti-apoptotic pathways eliminates senescent melanocytes and leads to nevi regression
Nature Communications
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Carl June, MD
University of Pennsylvania
Raquel Gur, MD
University of Pennsylvania
Howard Herrmann, MD
University of Pennsylvania
Robert Vonderheide, MD
University of Pennsylvania
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”